Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Accurate and rapid detection of tuberculosis (TB) and drug resistance are
critical for improving patient care and decreasing the spread of TB. Xpert® MTB/RIF assay …

Background While tuberculosis incidence and mortality are declining in South Africa,
meeting the goals of the End TB Strategy requires an invigorated programmatic response …

Background Microbiological confirmation of childhood tuberculosis is rare because of the
difficulty of collection of specimens, low sensitivity of smear microscopy, and poor access to …

Summary Background The Xpert MTB/RIF test for tuberculosis is being rolled out in many
countries, but evidence is lacking regarding its implementation outside laboratories, ability to …

Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

The goals of the End TB strategy, which aims to achieve a 90% reduction in tuberculosis
(TB) incidence and a 95% reduction in TB mortality by 2035, will not be achieved without …

Background Abundant evidence on Xpert MTB/RIF accuracy for diagnosing tuberculosis
(TB) and rifampicin resistance has been produced, yet there are few data on the population …

In tuberculosis-endemic settings, patients are often treated empirically, meaning that they
are placed on treatment based on clinical symptoms or tests that do not provide a …

Background Truenat is a novel molecular assay that rapidly detects tuberculosis (TB) and
rifampicin-resistance. Due to the portability of its battery-powered testing platform, it may be …